170 related articles for article (PubMed ID: 35795037)
1. Clinical Diagnostic and Prognostic Potential of
Xu S; Gao R; Zhou Y; Yang Y; Zhang Y; Li Q; Luo C; Liu SM
Front Oncol; 2022; 12():862216. PubMed ID: 35795037
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and biological role of the N-Myc downstream-regulated gene family in hepatocellular carcinoma.
Yin X; Yu H; He XK; Yan SX
World J Clin Cases; 2022 Mar; 10(7):2072-2086. PubMed ID: 35321174
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the prognostic values of the
Yu C; Hao X; Zhang S; Hu W; Li J; Sun J; Zheng M
Therap Adv Gastroenterol; 2019; 12():1756284819858507. PubMed ID: 31384305
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
[TBL] [Abstract][Full Text] [Related]
5. LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression.
Wang B; Chen L; Li Q; Zhou J; Jin W
Transl Cancer Res; 2023 May; 12(5):1290-1306. PubMed ID: 37304553
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of MICALL1 and associates with immune infiltration in liver hepatocellular carcinoma patients.
Yang Y; Zhao W; Du J; Wang Y
Cancer Biomark; 2023; 37(3):147-160. PubMed ID: 37248888
[TBL] [Abstract][Full Text] [Related]
7. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
Qi LW; Jia JH; Jiang CH; Hu JM
Front Genet; 2020; 11():614566. PubMed ID: 33519919
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
Han X; Long W; Liu Y; Xu J
Front Surg; 2022; 9():985034. PubMed ID: 36338652
[TBL] [Abstract][Full Text] [Related]
9. Systematic Analyses of the Role of the Reader Protein of
Shao XY; Dong J; Zhang H; Wu YS; Zheng L
Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
[TBL] [Abstract][Full Text] [Related]
10. Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma.
Wu J; Sun M; Li Z; Shen Y; Wu Y; Zhang H; Xu Z; Gao Q
J Gastrointest Oncol; 2023 Jun; 14(3):1434-1450. PubMed ID: 37435232
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma.
Liu C; Qu Z; Zhao H; Wang P; Zhan C; Zhang Y
BMC Bioinformatics; 2023 May; 24(1):192. PubMed ID: 37170221
[TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis.
He Q; Fan B; Du P; Jin Y
Front Cell Dev Biol; 2022; 10():806989. PubMed ID: 35356272
[No Abstract] [Full Text] [Related]
13. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
14. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.
Li TH; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB
Front Oncol; 2021; 11():665192. PubMed ID: 34123827
[TBL] [Abstract][Full Text] [Related]
15. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
Front Oncol; 2020; 10():603480. PubMed ID: 33425760
[TBL] [Abstract][Full Text] [Related]
16. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
[No Abstract] [Full Text] [Related]
17. Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.
Kui XY; Gao Y; Liu XS; Zeng J; Yang JW; Zhou LM; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Oncol; 2022; 12():809847. PubMed ID: 35957868
[TBL] [Abstract][Full Text] [Related]
18. NDRG1 was downregulated and worked as favorable biomarker in the development of gastric cancer.
Xiao XJ; Zheng HC
Transl Cancer Res; 2020 Jan; 9(1):210-221. PubMed ID: 35117175
[TBL] [Abstract][Full Text] [Related]
19. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family.
Qu X; Zhai Y; Wei H; Zhang C; Xing G; Yu Y; He F
Mol Cell Biochem; 2002 Jan; 229(1-2):35-44. PubMed ID: 11936845
[TBL] [Abstract][Full Text] [Related]
20. Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining.
Lin J; Chen L; Wu D; Lin J; Liu B; Guo C
Comput Math Methods Med; 2022; 2022():1372879. PubMed ID: 35813444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
